NYSE:MLSS

Milestone Scientific (MLSS) Stock Price, News & Analysis

$0.54
-0.01 (-1.82%)
(As of 04/22/2024 ET)
Today's Range
$0.54
$0.58
50-Day Range
$0.54
$0.78
52-Week Range
$0.52
$1.35
Volume
131,659 shs
Average Volume
82,389 shs
Market Capitalization
$41.36 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
MLSS stock logo

About Milestone Scientific Stock (NYSE:MLSS)

Milestone Scientific Inc., a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. In addition, the company offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances, and disposable injection handpiece for the tactile control during the injection. Further, it provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications. Additionally, the company offers company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey.

MLSS Stock Price History

MLSS Stock News Headlines

[Shocking] Elon Musk’s Plan To End Banks
Leaked Elon Musk call reveals shocking plan to replace banks. As Musk's plan rolls out, industry experts predict it could spark a wave of mass crypto adoption. Triggering a new crypto bull run. While helping drive a booming crypto asset class up from $2.5-billion to $16-trillion (a 6,400x increase) by 2030.
Q4 2023 Milestone Scientific Inc Earnings Call
Milestone Scientific earnings preview: what to expect
[Shocking] Elon Musk’s Plan To End Banks
Leaked Elon Musk call reveals shocking plan to replace banks. As Musk's plan rolls out, industry experts predict it could spark a wave of mass crypto adoption. Triggering a new crypto bull run. While helping drive a booming crypto asset class up from $2.5-billion to $16-trillion (a 6,400x increase) by 2030.
Milestone Scientific Inc.
Milestone Scientific Inc. (MLSS)
See More Headlines
Receive MLSS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Milestone Scientific and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/29/2024
Today
4/23/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical appliances & supplies
Sub-Industry
N/A
Employees
17
Year Founded
N/A

Profitability

Net Income
$-6,930,000.00
Pretax Margin
-71.04%

Debt

Sales & Book Value

Annual Sales
$9.83 million
Book Value
$0.11 per share

Miscellaneous

Free Float
57,298,000
Market Cap
$41.36 million
Optionable
Optionable
Beta
0.98
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Key Executives

  • Mr. Jan Adriaan Haverhals (Age 62)
    President, CEO & Director
    Comp: $680.26k
  • Mr. Leonard A. Osser (Age 77)
    Founder & Vice Chairman
  • Mr. Andy Molnar (Age 62)
    Senior Vice President of Global Sales & Business Development for Dental
  • Keisha Harcum
    Controller

MLSS Stock Analysis - Frequently Asked Questions

How have MLSS shares performed in 2024?

Milestone Scientific's stock was trading at $0.6899 at the beginning of the year. Since then, MLSS stock has decreased by 21.7% and is now trading at $0.54.
View the best growth stocks for 2024 here
.

How were Milestone Scientific's earnings last quarter?

Milestone Scientific Inc. (NYSE:MLSS) issued its earnings results on Friday, March, 29th. The company reported ($0.03) earnings per share (EPS) for the quarter. The business had revenue of $2.26 million for the quarter. Milestone Scientific had a negative net margin of 70.50% and a negative trailing twelve-month return on equity of 86.72%.

What other stocks do shareholders of Milestone Scientific own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Milestone Scientific investors own include AcelRx Pharmaceuticals (ACRX), Aptinyx (APTX), Axcella Health (AXLA), Aytu BioPharma (AYTU), Calithera Biosciences (CALA), Cidara Therapeutics (CDTX), Catalyst Pharmaceuticals (CPRX), DURECT (DRRX), Geron (GERN) and

How do I buy shares of Milestone Scientific?

Shares of MLSS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:MLSS) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners